KONTULIS CAITLIN (Secretary & Dir. of Finance) reported 2 transactions at PHIO PHARMACEUTICALS CORP.
Review the transaction codes below to understand the nature of each event.
Filed: 2/20/2024ACC: 0001683168-24-001086
Officer· Secretary & Dir. of Finance
Since Aug 2018
-1.18K
Net shares
Net seller
$772.88
Total sold
0
Open market trades
0B · 0S
2
Total transactions
1.18K disposed
Non-Derivative Transactions2
Common stock, $0.0001 par value
Direct
Shares
−658.00
Price / share
$0.65
Trade value
$427.70
% of position
5.4%
2/15/2024
12.16K→11.50K
Common stock, $0.0001 par value
Direct
Shares
−523.00
Price / share
$0.66
Trade value
$345.18
% of position
4.5%
2/17/2024
11.50K→10.98K
Total
Net shares
−1.18K
Net value
-$772.88
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 2/15/2024 | F · Tax Withholding | −658.00 | $0.65 | $427.70 | 5.4% | 12.16K | 11.50K |
| Common stock, $0.0001 par value Direct | 2/17/2024 | F · Tax Withholding | −523.00 | $0.66 | $345.18 | 4.5% | 11.50K | 10.98K |
| Total | −1.18K | -$772.88 | ||||||
Derivative Transactions0
No derivative transactions reported